Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization

被引:0
|
作者
Zeyneloglu, HB
Isik, AZ
Kara, S
Senöz, S
Özcan, U
Gökmen, O
机构
[1] Dr ZT Burak Womens Hosp, Dept Reprod Endocrinol, Ankara, Turkey
[2] Dr ZT Burak Womens Hosp, IVF Unit, Ankara, Turkey
关键词
fertilization in vitro; ovarian cysts; gonadotropin-releasing hormone agonist; ovarian stimulation;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective-To assess the effects of cysts developed prior to the commencement of luteal phase gonadotropin-releasing-hormone-agonist (GnRH-a) in IVF cycles. Design-Retrospective analysis. Setting-In vitro fertilization program in a tertiary hospital infertility clinic. Patients-Women stimulated for IVF-ET. All stimulations were down-regulated with GnRH-a commenced on day 21 in a long protocol before gonadotropin stimulation. Main Outcome Measure-Pregnancy rate. Results-Twenty-five of 121 cycles had cysts >15 mm (20.6%); these were classified as baseline (nonfunctional) (n = 12) or corpus luteum (n = 13) cysts. They had significantly longer suppression periods and lower peak estradiol levels, and used more gonadotropins during stimulation. Cysts had no impact on the number of oocytes collected or fertilization and pregnancy rates. Patients with baseline cysts had a greater duration of suppression and required more gonadotropin than those with corpus luteum cysts or those without cysts. The cycle outcomes were similar between the groups, but baseline cyst formation is likely to increase the cost of IVF. Conclusion-These findings suggest that baseline cyst formation causes longer suppression duration and greater gonadotropin utilization, although an impact on pregnancy rates is unlikely.
引用
收藏
页码:300 / 305
页数:6
相关论文
共 50 条
  • [21] Model of gonadotropin-releasing hormone and gonadotropin-releasing hormone complex
    Viroj Wiwanitkit
    Sexuality and Disability, 2006, 24 : 175 - 178
  • [22] INTRANASAL ADMINISTRATION OF SYNTHETIC GONADOTROPIN-RELEASING HORMONE
    JEPPSSON, S
    KULLANDER, S
    RANNEVIK, G
    THORELL, J
    BMJ-BRITISH MEDICAL JOURNAL, 1973, 4 (5886): : 231 - 231
  • [23] PULSATILE ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE (GNRH)
    KEOGH, EJ
    GILES, PFH
    BERTOLINI, J
    MCCOLM, SC
    MALLAL, SA
    SOMERVILLE, CP
    BYRNE, SA
    MARTIN, CE
    DUNN, AG
    CLARKE, IJ
    ATTIKIOUZEL, J
    MARSHALL, T
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, 9 (05) : 529 - 530
  • [24] Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs
    Orvieto, Raoul
    Kruchkovich, Jenny
    Rabinson, Jacob
    Zohav, Efraim
    Anteby, Eyal Y.
    Meltcer, Simion
    FERTILITY AND STERILITY, 2008, 90 (01) : 228 - 230
  • [25] The Effects of gonadotropin-releasing hormone analog and a combination of gonadotropin-releasing hormone analog and recombinant human growth hormone on adult height in girls with early puberty
    Hajzadeh, Ghodsieh
    Ghaemi, Norsrat
    Hadjzadeh, Mousa-Al-Reza
    Noroozi, Samaneh
    Morovatdar, Negar
    ADVANCED BIOMEDICAL RESEARCH, 2019, 8 (01): : 57
  • [26] UNSUSPECTED LEIOMYOSARCOMA - TREATMENT WITH A GONADOTROPIN-RELEASING HORMONE ANALOG
    MEYER, WR
    MAYER, AR
    DIAMOND, MP
    CARCANGIU, ML
    SCHWARTZ, PE
    DECHERNEY, AH
    OBSTETRICS AND GYNECOLOGY, 1990, 75 (03): : 529 - 532
  • [27] Induction of luteinizing hormone surge by pulsatile administration of gonadotropin-releasing hormone analogue in cows with follicular cysts
    Kawate, N
    Yamada, H
    Suga, T
    Inaba, T
    Mori, J
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1997, 59 (06): : 463 - 466
  • [28] TREATMENT OF CRYPTORCHIDISM WITH A POTENT ANALOG OF GONADOTROPIN-RELEASING HORMONE
    HAPP, J
    WEBER, T
    CALLENSEE, W
    ERMERT, JA
    ESHKOL, A
    BEYER, J
    FERTILITY AND STERILITY, 1978, 29 (05) : 552 - 556
  • [29] Combined Administration of Gonadotropin-releasing Hormone Agonist with Human Chorionic Gonadotropin for Finall Oocyte Maturation in GnRH Antagonist Cycles for in Vitro Fertilization
    Kim, Chung-Hoon
    Ahn, Jun-Woo
    You, Rae-Mi
    Kim, Sung-Hoon
    Chae, Hee-Dong
    Kang, Byung-Moon
    JOURNAL OF REPRODUCTIVE MEDICINE, 2014, 59 (1-2) : 63 - 68
  • [30] Gonadotropin-releasing hormone/gonadotropin-releasing hormone receptor signaling in the placenta
    Sasaki, Kirsten
    Norwitz, Errol R.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (06) : 401 - 408